Bill117th CongressFiled Nov 16, 2022Health
H.R. 9321
Independent Drug Value Assessment Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Nov 16, 2022)
Independent Drug Value Assessment Act
This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).
What just happenedNov 17, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Speier, Jackie [D-CA-14](D-CA)Sponsor
2 cosponsors2 D
2cosponsors1committees4actions
- Introduced in HouseNov 16, 2022
- Nov 17, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 16, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Nov 16, 2022IntroReferralIntro-H
Introduced in House
- Nov 16, 2022IntroReferral1000
Introduced in House